Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mitchell, Wortzman"'
Autor:
Joely, Kaufman, Valerie, Callender, Cherie, Young, Patricia, Jones, Mitchell, Wortzman, Diane, Nelson
Publikováno v:
Journal of Drugs in Dermatology. 21:932-937
The periorbital region is susceptible to premature skin aging and among the first areas to manifest age-related changes. Retinoids are highly effective but can be irritating, limiting use in this vulnerable area. A hydrating formulation comprised of
Publikováno v:
Journal of drugs in dermatology : JDD. 21(1)
Topical retinoids influence the rate of cellular turnover and improve skin clarity and photoaged skin. Consequent cutaneous irritation reduces adherence resulting in suboptimal outcomes. A formulation comprised of a double-conjugated molecule contain
Publikováno v:
Journal of Cosmetic Dermatology. 16:542-548
SummaryBackground Topical retinoids are used to treat the visible signs of photoaging. While efficacious, they are irritating. Objective Evaluate the effectiveness and tolerability of a double-conjugate retinoid cream (AlphaRet Overnight Cream; AHA-R
Publikováno v:
Journal of drugs in dermatology : JDD. 18(7)
Background: Pigmentation disorders are therapeutically challenging to treat, requiring complicated regimens. Objectives: Alternatives to hydroquinone (HQ) are desired. We evaluated the efficacy and tolerability of a non-HQ multi-action skin tone corr
Autor:
David H, McDaniel, Jacob M, Waugh, Lily I, Jiang, Thomas J, Stephens, Alex, Yaroshinsky, Chris, Mazur, Mitchell, Wortzman, Diane B, Nelson
Objectives: Investigators sought to evaluate the antioxidant capacity of a comprehensive topical antioxidant (WEL-DS), its ability to protect skin against the oxidizing effects of UVA/UVB radiation, and to assess the effectiveness and tolerability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c07c834e979782e8aaa3fef984bc3588
https://europepmc.org/articles/PMC6508483/
https://europepmc.org/articles/PMC6508483/
Autor:
Andy Pickett, Mitchell Wortzman
Publikováno v:
Aesthetic Surgery Journal. 29:S34-S42
Background: Since the first comprehensive description of the physiologic effects of botulism toxicity in the 1820s, specific formulations of botulinum neurotoxin type A (BoNT-A) have been developed. Now, a new botulinum neurotoxin type A formulation
Publikováno v:
Pediatric Dermatology. 26:257-261
Treatments for mild to moderately severe acne usually combine retinoid and antimicrobial therapy. Recently, the US FDA approved the combination of 1.2% clindamycin (CLIN) and 0.025% tretinoin (RA) in a novel gel formulation for the treatment of mild
Autor:
Ronda M. Williams, Monica Jeffers, Ronald L. Moy, Serene L. Nguyen, Tamy Ottomeyer, Hayes Gladstone, Mitchell Wortzman
Publikováno v:
Dermatologic Surgery. 26:333-337
Salicylic acid, hydroquinone, and glycolic acid have been proved effective in the treatment of photodamaged facial skin. Few reports are available on the treatment of photodamage on the neck and upper chest.This study's purpose was to evaluate the ef
Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review
Autor:
Michael A. C. Kane, Joel Schlessinger, John H Joseph, David J Applebaum, Sue Ellen Cox, Ira Lawrence, Z. Paul Lorenc, Amir Moradi, Corey S. Maas, Julius W. Few, Vivian W Bucay, Leslie Baumann, Xiaoming Lin, Mitchell Wortzman, Mark S Nestor, Shawn Allen, Diane B. Nelson
Publikováno v:
Aesthetic surgery journal. 32
The amount and complexity of scientific and clinical evidence for aesthetic use of botulinum neurotoxin type A (BoNT-A) has expanded rapidly in recent years, especially for abobotulinumtoxinA, necessitating reassessment of current knowledge about aes
Publikováno v:
Journal of drugs in dermatology : JDD. 8(4)
Newer agents and formulations seek to improve the tolerability of topical retinoid therapy. Recently, a gel containing crystalline clindamycin 1.2% and tretinoin 0.025% (CLIN/RA) was approved by the U.S. Food and Drug Administration (FDA) for the tre